Jarrett Disbrow, Chief Business Officer at Aytu Biopharma ($AYTU), made one open market purchase of company shares worth $25,000 in the last year. His most recent buy occurred on June 9, 2025. Among nearly 5,000 insiders tracking open market buys, Disbrow's activity ranks 3,619th by purchase value, well below the average of $1.5 million across 3.3 transactions. He reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 3, 2025 | AYTU BIOPHARMA, INC | $AYTU | Disbrow Jarrett | Chief Business Officer | A | Common Stock | 19606 | $0.00 | 49,068.0000 | 19,476,635 | 66.55% | 0.10% |
| Oct. 3, 2025 | AYTU BIOPHARMA, INC | $AYTU | Disbrow Jarrett | Chief Business Officer | A | Common Stock | 12500 | $0.00 | 61,568.0000 | 19,476,635 | 25.47% | 0.06% |
| June 9, 2025 | AYTU BIOPHARMA, INC | $AYTU | Disbrow Jarrett | Chief Business Officer | P | Common Stock | 16666 | $1.50 | 29,462.0000 | 8,782,794 | 130.24% | 0.19% |
| Nov. 6, 2024 | AYTU BIOPHARMA, INC | $AYTU | Disbrow Jarrett | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 7000 | $0.00 | 7,000.0000 | 9,099,601 | 9999.99% | 0.08% |
| Aug. 11, 2023 | AYTU BIOPHARMA, INC | $AYTU | Disbrow Jarrett | Chief Business Officer | A | Employee Stock Option (Right to Buy) | 7000 | $0.00 | 7,000.0000 | 0 | 9999.99% | 0.00% |